Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn't?
- PMID: 34400936
- PMCID: PMC8170762
- DOI: 10.22037/ijpr.2021.115076.15183
Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn't?
References
-
- He XJ, Dai RX, Hu CL. Maternal prepregnancy overweight and obesity and the risk of preeclampsia: A meta-analysis of cohort studies. Obes. Res. Clin. Pract. . 2020;14:27–33. - PubMed
-
- Benkő Z, Wright A, Rehal A, Cimpoca B, Syngelaki A, Delgado J, Tsokaki T, De Alvarado M, Vojtassakova D, Malligiannis Ntalianis K. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks’ gestation: data from EVENTS trial. Ultrasound Obstet. Gynecol. . 2021;57:257–65. - PubMed
-
- Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Heath P, Ladhani S, von Dadelszen P, Magee LA. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine . 2020;25:100446. - PMC - PubMed
-
- Halscott T, Vaught J. Society for maternal-fetal medicine management considerations for pregnant patients with COVID-19. SFMF Guideline . 2021;2021:26–7.
LinkOut - more resources
Full Text Sources